1. Home
  2. SPT vs MOBI Comparison

SPT vs MOBI Comparison

Compare SPT & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPT

Sprout Social Inc

HOLD

Current Price

$8.44

Market Cap

485.7M

Sector

Technology

ML Signal

HOLD

Logo Mobia Medical Inc. Common Stock

MOBI

Mobia Medical Inc. Common Stock

N/A

Current Price

$10.70

Market Cap

399.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SPT
MOBI
Founded
2010
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
485.7M
399.7M
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
SPT
MOBI
Price
$8.44
$10.70
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$11.75
N/A
AVG Volume (30 Days)
925.9K
81.1K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
32.11
N/A
EPS
N/A
N/A
Revenue
$457,547,000.00
N/A
Revenue This Year
$8.86
N/A
Revenue Next Year
$8.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.72
N/A
52 Week Low
$4.92
$10.34
52 Week High
$16.03
$15.19

Technical Indicators

Market Signals
Indicator
SPT
MOBI
Relative Strength Index (RSI) 55.28 40.39
Support Level $7.47 $10.56
Resistance Level $9.12 $11.61
Average True Range (ATR) 0.48 0.76
MACD -0.01 -0.03
Stochastic Oscillator 60.10 29.12

Price Performance

Historical Comparison
SPT
MOBI

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.

About MOBI Mobia Medical Inc. Common Stock

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.

Share on Social Networks: